Clinical Trial Update: Eucrisa for Atopic Dermatitis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Eucrisa (crisaborole) for mild to moderate atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Eucrisa (crisaborole)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Mild to Moderate Atopic Dermatitis | Phase 1 | Status: COMPLETED